-+ 0.00%
-+ 0.00%
-+ 0.00%

Denali Therapeutics announces annual shareholder meeting via webcast

PUBT·04/21/2026 20:34:09
Listen to the news
Denali Therapeutics announces annual shareholder meeting via webcast
  • Denali Therapeutics set annual shareholder meeting for June 3, 2026 via virtual webcast.
  • Shareholders will vote on election of three Class III directors to serve until 2029.
  • Meeting agenda includes ratification of Ernst & Young as independent auditor for fiscal 2026.
  • Investors will also cast advisory vote on executive compensation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Denali Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001714899-26-000054), on April 21, 2026, and is solely responsible for the information contained therein.